Magnetic resonance imaging of the prostate

Current Opinion in Urology

Volumn 11, Issue 2, 2001, Pages 181-188

  Rørvik, Jarle ^a   Haukaas, Svein ^a  

^a HAUKELAND UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; BENIGN TUMOR; DIAGNOSTIC VALUE; DIFFERENTIAL DIAGNOSIS; HUMAN; MALIGNANT NEOPLASTIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROSTATE CANCER; TECHNOLOGY;

ADENOCARCINOMA; FOLLOW-UP STUDIES; FORECASTING; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; NEOPLASM STAGING; PROSTATIC HYPERPLASIA; PROSTATIC NEOPLASMS;

EID: 0035111873     PISSN: 09630643     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042307-200103000-00009     Document Type: Article

References (52)

1. Preliminary results of a bone marrow magnetic resonance imaging protocol for patients with high-risk prostate cancer
2. Lymph node metastases: Safety and effectiveness of MR imaging with ultrasmall super paramagnetic iron oxide particles. Initial clinical experience
3. MR lymphangiography using ultrasmall superparamagnetic iron oxide in patients with primary abdominal and pelvic malignancies: Radiographic-pathologic correlation
4. Anatomy and pathology of the male pelvis by magnetic resonance imaging
5. Magnetic resonance imaging of the prostate
6. Prostatic carcinoma and benign prostatic hyperplasia: Inability of MR imaging to distinguish between the two diseases
7. MR depiction of zonal anatomy of the prostate at 1.5 T
8. Normal prostate and adjacent structures: MR imaging at 1.5 T
9. Comparison of magnetic resonance imaging and ultrasonography in staging early prostate cancer. Results of a multi-institutional cooperative trial
10. Carcinoma of the prostate: MR images obtained with body coils do not accurately reflect tumor volume
11. MR imaging in adenocarcinoma of the prostate: Interobserver variation and efficacy for determining stage C disease
12. Current role of MR imaging in the staging of adenocarcinoma of the prostate
13. Carcinoma of the prostate gland: MR imaging with pelvic phased-array versus integrated endorectal-pelvic phased-array coils
14. Staging of prostate cancer: Results of Radiology Diagnostic Oncology Group project comparison of three MR imaging techniques
15. Staging of prostatic cancer: Accuracy of MR imaging
16. MRI with an endorectal coil for staging of clinically localized prostate cancer prior to radical prostatectomy
17. Detection of extracapsular extension of prostate carcinoma with endorectal and phased-array coil MR-imaging: Multivariate feature analysis
18. Dynamic turboflash subtraction technique for contrast-enhanced MR imaging of the prostate: Correlation with histopathologic results
19. Update on the staging for newly diagnosed prostate cancer
20. Current trends in prostate cancer diagnosis and staging among United States urologists
21. Magnetic resonance imaging of prostate cancer: Comparison of image quality using endorectal and pelvic phased array coils
22. Uptake of a superparamagnetic contrast agent imaged by MR with high spectral and spatial resolution
23. Towards multidimensional radiotherapy (MD-CRT): Biological imaging and biological conformality
24. Oncogenes, cancer and imaging
25. Transrectal US and endorectal MR imaging in partial and complete obstruction of seminal duct system. A comparative study
26. Multilocular cystic adenomyoma of the pelvic cavity: A rare clinical and histological entity in a young man
27. Benign prostatic hyperplasia: Value of MR imaging for determining histologic type
28. Prostatic growth rate determined from MRI data: Age-related longitudinal changes
29. Prediction of alpha-blocker response in men with benign prostatic hyperplasia by magnetic resonace imaging
30. Differentiation of prostatic carcinoma and benign prostatic hyperplasia: Correlation between dynamic Gd-DTPA-enhanced MR imaging and histopathology
31. The transrectal ultrasound and MRI appearances of granulomatous prostatitis and its differentiation from carcinoma
32. Prostate cancer staging: Should MR imaging be used? A decision analytic approach
33. Review of staging modalities in clinically localized prostate cancer
34. Magnetisk resonanstomografi med endorektal spole for under-søkelse av prostata og sædblærene
35. Magnetic resonance imaging of prostatic cancer: Does detection vary between high and low Gleason score tumours?
36. Dynamic contrast enhanced MRI of prostate cancer: Correlation with morphology and tumour stage, histological grade and PSA
37. Prostate cancer: Localization with three-dimensional proton MR spectroscopic imaging clinocopathologic study
38. MRI characterization of tumours and grading angiogenesis using macromolecular contrast media: Status report
39. Combination of the preoperative PSA level, biopsy Gleason score, percentage of positive biopsy and MRI T-stage to predict early PSA failure in men with clinically localized prostate cancer
40. Endorectal magnetic resonance imaging as a predictor of biochemical outcome after radical prostatectomy in men with clinically localized prostate cancer
41. Prostate cancer: Prediction of extracapsular extension with endorectal MR imaging and three-dimensional proton MR spectroscopic imaging
42. The national cancer data base report on increased use of brachytherapy for treatment of patients with prostatic carcinoma in the US
43. Identifying the predictors of acute urinary retention following magnetic-resonance-guided prostate brachytherapy
44. Evaluating the effect of rectal distension and rectal movement on prostate gland position using cine MRI
45. Three-dimensional real-time magnetic resonance-guided interstitial prostate brachytherapy optimizes radiation dose distribution resulting in a favorable acute side effect profile in patients with clinically localized prostate cancer
46. Comparison of MRI with CT for the radiotherapy planning of prostate cancer: A feasibility study
47. Static field intensity modulation to treat a dominant intra-prostatic lesion to 90Gy compared to seven field 3-dimensional radiotherapy
48. The prostate gland: Malignancies other than adenocarcinomas
49. Transrectal ultrasound applicator for prostate heating monitored using MRI thermometry
50. Synergistic interaction of ultrasonic shock waves and hyperthermia in the Dunning prostate tumor. R3327-AT1
51. Rapid in vivo monitoring of chemotherapeutic response using weighted sodium magnetic resonance imaging
52. Imaging prostate cancer invasion with multinuclear magnetic resonance methods: The metabolic boyden chamber